Douglas Steel, PhD is the Founder and Chief Scientific Officer of NeuroSense. He has over 30 years of experience in pharmaceutical drug design and discovery, and research project management and implementation divided between academia and the pharmaceutical industry.

He has received training in medical sciences and neuroscience, theoretical and applied biotechnology, integrative neuroscience, and brain-environment interactions. He is the author of over 20 publications in scientific journals and books in the areas of drug design, drug discovery, and marine biochemistry. He has also written over 30 technology articles in the popular press.

Doug was an NIH postdoctoral research fellow in the Neuroscience Program at the University of Utah. He holds a PhD (Biomedical Sciences, Columbia University), an MPhil (Pathology, Columbia), an MS (Psychobiology, U of Florida, and a BA (Biology, Kalamazoo College). He also held pharmaceutical research positions at The Upjohn Company, CIBA-Geigy, and Syntex Pharmaceuticals.

In other ventures, Doug is also the Creative Director of iE, an art, technology, and design practice that works with interactive lighting technology as a medium of artistic expression and scientific data representation. He develops the conceptual themes of projects and specifies the physical form that will be designed and built to convey the impressions and information associated with the installation. http://www.ieworlds.com

iE is the artistic extension of DaVinci’s Workshop Inc. (http://www.davincisworkshop.com), a technology development and product prototyping studio. The two entities collaborate on artistic installations that have neuroscience or programmable LED components. He is responsible for identifying market opportunities, and managing the research and commercial development of new products and applications.